Literature DB >> 20486954

Takotsubo cardiomyopathy induced by dobutamine infusion: a new phenomenon or an old disease with a new name.

William J Mosley1, Amin Manuchehry, Colleen McEvoy, Vera Rigolin.   

Abstract

Takotsubo cardiomyopathy mimics acute myocardial infarction but is a separate clinical entity characterized by distinct wall motion abnormalities in the absence of obstructive coronary lesions. The prevalence of this condition is relatively uncommon yet has gained increasing recognition in recent years. It has rarely been associated with the use of dobutamine infusion during cardiac stress testing. We present in detail two cases of dobutamine-induced Takotsubo cardiomyopathy from our case series, one from 2002 and the other from 2008. While both cases display the typical features of Takotsubo cardiomyopathy, the former was initially diagnosed as dobutamine-induced vasospasm. These cases may provide insight into the pathophysiological mechanism of the condition and suggest that the increasing recognition of Takotsubo cardiomyopathy results from increasing familiarity of the condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486954     DOI: 10.1111/j.1540-8175.2009.01089.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  13 in total

1.  Takotsubo cardiomyopathy after midodrine therapy.

Authors:  Vijay S Ramanath; Bruce W Andrus; Carl R Szot; Aaron V Kaplan; John F Robb
Journal:  Tex Heart Inst J       Date:  2012

Review 2.  How to increase the utilization of donor hearts?

Authors:  Maya Guglin
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

3.  Takotsubo cardiomyopathy occurring during the recovery period of dobutamine stress echocardiography.

Authors:  John S Ho; Riva L Rahl; John J Cannaday; Reena Patel; Addie Engstrom; Yvette L Henderson; Maureen Ramsay
Journal:  J Cardiol Cases       Date:  2012-04-19

4.  Takotsubo cardiomyopathy with use of salbutamol nebulisation and aminophylline infusion in a patient with acute asthma exacerbation.

Authors:  Yousuf Hasan Khwaja; Javed Majid Tai
Journal:  BMJ Case Rep       Date:  2016-10-28

5.  Use of the Impella 2.5 left ventricular assist device in a patient with cardiogenic shock secondary to takotsubo cardiomyopathy.

Authors:  Ahmed Rashed; Sekon Won; Marwan Saad; Theodore Schreiber
Journal:  BMJ Case Rep       Date:  2015-05-07

6.  Dissociation between severity of takotsubo cardiomyopathy and presentation with shock or hypotension.

Authors:  Cher-Rin Chong; Christopher J Neil; Thanh H Nguyen; Jeanette Stansborough; Gin Way Law; Kuljit Singh; John D Horowitz
Journal:  Clin Cardiol       Date:  2013-04-12       Impact factor: 2.882

7.  Heart Rate Variability as a Biomarker of Neurocardiogenic Injury After Subarachnoid Hemorrhage.

Authors:  Murad Megjhani; Farhad Kaffashi; Kalijah Terilli; Ayham Alkhachroum; Behnaz Esmaeili; Kevin William Doyle; Santosh Murthy; Angela G Velazquez; E Sander Connolly; David Jinou Roh; Sachin Agarwal; Ken A Loparo; Jan Claassen; Amelia Boehme; Soojin Park
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

8.  Reverse Takotsubo Cardiomyopathy Precipitated by Chronic Cocaine and Cannabis Use.

Authors:  Emily Nash; Darren M Roberts; Nazila Jamshidi
Journal:  Cardiovasc Toxicol       Date:  2021-08-24       Impact factor: 3.231

9.  Takotsubo Cardiomyopathy: A New Perspective in Asthma.

Authors:  Fady Y Marmoush; Mohamad F Barbour; Thomas E Noonan; Mazen O Al-Qadi
Journal:  Case Rep Cardiol       Date:  2015-07-12

Review 10.  The spectrum of cardiovascular effects of dobutamine - from healthy subjects to septic shock patients.

Authors:  Arnaldo Dubin; Bernardo Lattanzio; Luis Gatti
Journal:  Rev Bras Ter Intensiva       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.